These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 16431890

  • 1. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
    Grobner T.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
    [No Abstract] [Full Text] [Related]

  • 2. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K, Ezell LD, Macklin JG.
    Nephrol Nurs J; 2007 Apr; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR, Jagirdar J.
    J Comput Assist Tomogr; 2008 Apr; 32(1):1-3. PubMed ID: 18303280
    [Abstract] [Full Text] [Related]

  • 4. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis.
    High WA, Ayers RA, Cowper SE.
    J Am Acad Dermatol; 2007 Apr; 56(4):710-2. PubMed ID: 17289213
    [No Abstract] [Full Text] [Related]

  • 5. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS, Sanyal S, Abraham JL.
    J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
    [Abstract] [Full Text] [Related]

  • 6. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M, Davenport A, Clatworthy I, Lewin J, Deroide F, Hubbard V, Rustin MH.
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
    Moreno-Romero JA, Segura S, Mascaró JM, Cowper SE, Julià M, Poch E, Botey A, Herrero C.
    Br J Dermatol; 2007 Oct; 157(4):783-7. PubMed ID: 17627792
    [Abstract] [Full Text] [Related]

  • 8. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J.
    Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract] [Full Text] [Related]

  • 9. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE, Sviland L, Sekse I, Svarstad E.
    Tidsskr Nor Laegeforen; 2009 Jan 29; 129(3):180-2. PubMed ID: 19180161
    [Abstract] [Full Text] [Related]

  • 10. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Weiss AS, Lucia MS, Teitelbaum I.
    Nat Clin Pract Nephrol; 2007 Feb 29; 3(2):111-5. PubMed ID: 17251999
    [Abstract] [Full Text] [Related]

  • 11. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
    Galan A, Cowper SE, Bucala R.
    Curr Opin Rheumatol; 2006 Nov 29; 18(6):614-7. PubMed ID: 17053507
    [Abstract] [Full Text] [Related]

  • 12. The role of gadolinium in triggering nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
    Solomon GJ, Rosen PP, Wu E.
    Arch Pathol Lab Med; 2007 Oct 29; 131(10):1515-6. PubMed ID: 17922586
    [No Abstract] [Full Text] [Related]

  • 13. Nephrogenic fibrosing dermopathy: a case study.
    Sego S.
    Nephrol Nurs J; 2008 Oct 29; 35(1):67-8. PubMed ID: 18372766
    [Abstract] [Full Text] [Related]

  • 14. What is your diagnosis. Nephrogenic systemic fibrosis.
    Zaleski L, Xia Y, Cho S.
    Cutis; 2011 Jan 29; 87(1):13, 19-20. PubMed ID: 21323094
    [No Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.
    Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R.
    Clin J Am Soc Nephrol; 2007 Mar 29; 2(2):258-63. PubMed ID: 17699422
    [Abstract] [Full Text] [Related]

  • 16. [Nephrogenic systemic fibrosis or kidney failure--how great is the risk?].
    Rofo; 2010 Feb 29; 182(2):114-5. PubMed ID: 20120045
    [No Abstract] [Full Text] [Related]

  • 17. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
    Thomsen HS, Morcos SK, Dawson P.
    Clin Radiol; 2006 Nov 29; 61(11):905-6. PubMed ID: 17018301
    [No Abstract] [Full Text] [Related]

  • 18. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure].
    Michelet PR, Chopard CS, Martin PY, Vallée JP.
    Rev Med Suisse; 2008 Mar 05; 4(147):576-8, 580. PubMed ID: 18402015
    [Abstract] [Full Text] [Related]

  • 19. Case 35-2004: nephrogenic fibrosing dermopathy.
    Cowper SE, Bucala R, LeBoit PE.
    N Engl J Med; 2005 Apr 21; 352(16):1723-4; author reply 1723-4. PubMed ID: 15846862
    [No Abstract] [Full Text] [Related]

  • 20. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.
    Kucher C, Steere J, Elenitsas R, Siegel DL, Xu X.
    J Am Acad Dermatol; 2006 Feb 21; 54(2 Suppl):S31-4. PubMed ID: 16427988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.